AbbVie
ABBV
ABBV
2,001 hedge funds and large institutions have $80.2B invested in AbbVie in 2019 Q3 according to their latest regulatory filings, with 123 funds opening new positions, 858 increasing their positions, 797 reducing their positions, and 124 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
1% less first-time investments, than exits
New positions opened: 123 | Existing positions closed: 124
1% less funds holding
Funds holding: 2,020 → 2,001 (-19)
7% less call options, than puts
Call options by funds: $1.63B | Put options by funds: $1.75B
Holders
2,001
Holding in Top 10
73
Calls
$1.63B
Puts
$1.75B
Top Buyers
1 | +$1.11B | |
2 | +$800M | |
3 | +$695M | |
4 |
BlackRock
New York
|
+$253M |
5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$221M |
Top Sellers
1 | -$720M | |
2 | -$505M | |
3 | -$387M | |
4 |
![]()
Franklin Resources
San Mateo,
California
|
-$179M |
5 |
Citadel Advisors
Miami,
Florida
|
-$158M |